Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |